Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Reports Increased Losses, Going Concern Warning, and Massive Dilution Despite Recent $5M Capital Raise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.995
Mkt Cap
$2.448M
52W Low
$0.96
52W High
$43.176
52W Position info
3.6% above low
Off High info
98% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

NUWE is trading near its 52-week low of $0.96 (3.6% above the low).

Summary

Nuwellis reported widening Q1 losses, reiterated its 'going concern' warning and material weaknesses, and disclosed massive dilution from a recent $5.0 million capital raise, despite revenue growth and a strategic acquisition.


Key Events · Earnings and Guidance · NUWE

  • Going Concern Warning Reiterated

    The company continues to raise substantial doubt about its ability to continue as a going concern for at least the next twelve months, with existing capital sufficient only into Q2 2026.

  • Material Weaknesses in Internal Controls

    Nuwellis confirmed two material weaknesses in its internal controls over financial reporting, impacting the effectiveness of its disclosure controls.

  • Significant Dilutive Capital Raise

    A January 2026 private placement and warrant inducement generated $5.0 million in gross proceeds, but led to a 56% increase in outstanding common shares and potential future dilution of over 155% from new warrants.

  • Widening Net Loss Despite Revenue Growth

    Net sales increased 26.2% year-over-year to $2.4 million in Q1 2026, but net loss widened to $(4.5) million from $(3.0) million in the prior year, driven by increased operating expenses including R&D.


Analysis · NUWE · Industrial Applications And Services

Nuwellis's first-quarter results highlight severe financial distress, with the company reiterating a 'going concern' warning and disclosing material weaknesses in internal controls. Despite a 26.2% year-over-year revenue increase and a significant $5.0 million capital raise through a private placement and warrant inducement, net losses widened. The financing, while critical for extending the company's cash runway into Q2 2026, resulted in a 56% increase in outstanding shares and potential future dilution of over 155% from new warrants. The company also completed the acquisition of Rendiatech, expensing $757,000 in acquired R&D, further impacting profitability. The stock is trading near its 52-week low, making the substantial dilution particularly painful for existing shareholders.

At the time of this filing, NUWE was trading at $1.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.96 to $43.18. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.58
Real-time Price: $1.48 info
Change: -$0.0969 (-6%) info
Market Cap: $4.731M info
NUWE
Aug 03, 2026, 7:27 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.65
Real-time Price: $1.48 info
Change: -$0.1669 (-10%) info
Market Cap: $4.731M info
NUWE
Jul 31, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.48 info
Change: -$0.4869 (-25%) info
Market Cap: $4.731M info
NUWE
Jul 27, 2026, 8:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $1.48 info
Change: -$0.5069 (-25%) info
Market Cap: $4.731M info
NUWE
Jul 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.01
Real-time Price: $1.48 info
Change: -$0.5223 (-26%) info
Market Cap: $4.731M info